European Biotech EBACU Stock
European Biotech Price Chart
European Biotech EBACU Financial and Trading Overview
European Biotech stock price | 11.3 USD |
Previous Close | 10.9 USD |
Open | 11.97 USD |
Bid | 0 USD x 1100 |
Ask | 0 USD x 2200 |
Day's Range | 10.45 - 11.99 USD |
52 Week Range | 8.98 - 13.27 USD |
Volume | 5.71K USD |
Avg. Volume | 1.56K USD |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 82.48176 |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
EBACU Valuation Measures
Enterprise Value | 185.03M USD |
Trailing P/E | 82.48176 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
European Biotech Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | 15.07% |
S&P500 52-Week Change | -1.50% |
52 Week High | 13.27 USD |
52 Week Low | 8.98 USD |
50-Day Moving Average | 10.23 USD |
200-Day Moving Average | 10 USD |
EBACU Share Statistics
Avg. Volume (3 month) | 1.56K USD |
Avg. Daily Volume (10-Days) | 4.22K USD |
Shares Outstanding | N/A |
Float | 11.96M |
Short Ratio | 0 |
% Held by Insiders | 3.44% |
% Held by Institutions | 6.52% |
Shares Short | 0 |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | 860.48K USD |
Diluted EPS (ttm) | 0.137 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 272.63K USD |
Total Cash Per Share (mrq) | 0.02 USD |
Total Debt (mrq) | 0 USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.284 |
Book Value Per Share (mrq) | -0.369 |
Cash Flow Statement
Operating Cash Flow (ttm) | -803517 USD |
Levered Free Cash Flow (ttm) | N/A |
Profile of European Biotech
Country | United States |
State | N/A |
City | Amsterdam |
Address | Johannes Vermeerplein 9 |
ZIP | 1071 DV |
Phone | 31 20 664 55 00 |
Website | https://www.lspvc.com/ebac |
Industry | Shell Companies |
Sector(s) | Financial Services |
Full Time Employees | N/A |
European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on business in the life sciences industry in Europe. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.
Q&A For European Biotech Stock
What is a current EBACU stock price?
European Biotech EBACU stock price today per share is 11.3 USD.
How to purchase European Biotech stock?
You can buy EBACU shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for European Biotech?
The stock symbol or ticker of European Biotech is EBACU.
Which industry does the European Biotech company belong to?
The European Biotech industry is Shell Companies.
How many shares does European Biotech have in circulation?
The max supply of European Biotech shares is 0.
What is European Biotech Price to Earnings Ratio (PE Ratio)?
European Biotech PE Ratio is 0.00000000 now.
What was European Biotech earnings per share over the trailing 12 months (TTM)?
European Biotech EPS is 0 USD over the trailing 12 months.
Which sector does the European Biotech company belong to?
The European Biotech sector is Financial Services.